Page 46 - COVID Newsletter 11 June
P. 46
ensure evidence-based care for ICU patients. Their technology is cost effective, easy to deploy, with a low barrier of adoption for even technology-naive healthcare providers.
Contact info: info@cloudphysician.net
Website Link:
https://www.investindia.gov.in/bip/resources/innovations-against-covid-19 https://cloudphysician.net/
A start-up incubated at iCreate-Ahmedabad develops Venturi-valve
respirator to help coronavirus patients
Venturi-valve is an airflow control device developed by iCreate-incubated start-up at Ahmedabad. It controls airflow by varying its annular orifice to modulate the flow of air. The cone is situated on an actuated shaft, which enables flow control through the full range (0%- 100%) of the valve. The valve uses the Venturi effect to generate under pressure in a tube consisting of three parts - a convergent section (nozzle), followed by a constant section (throat), ending in a gradual expansion (diffuser). Due
A representative image of Venturi-valve respirator
to the oxygen flow under pressure generated
in the nozzle, the air is sucked into the valve. The valve is powered with a stream of pure oxygen with a flow rate of 10 1 pm. Two streams mix in a diffuser - oxygen (100% O2) and air (21% O2) - resulting in high flow, high oxygen stream at the outlet. The proposed method of production and the valve is preferably SLA or FDM and the material is PLA or ABS which are ideal due to their non-reactiveness to the oxygen. It is a single consolidated 3D printed part requiring no assembly.
Contact Info: info@icreate.org.in
Website link:
https://www.investindia.gov.in/bip/resources/innovations-against-covid-19 https://www.icreate.org.in/
Carenation remote care delivery platform developed by Teslon
Technologies
Carenation is an advanced remote healthcare delivery platform developed by Bengaluru-based start-up, Teslon Technologies Private Limited. The company offers two products, portable ICU Monitoring System and Patient App, for those quarantined and with mild symptoms.
VOL. IV ISSUE 4
VIGYAN PRASAR 42
NATION’S S&T EFFORTS AGAINST COVID-19